PT1112747E - Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos - Google Patents

Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos

Info

Publication number
PT1112747E
PT1112747E PT00204630T PT00204630T PT1112747E PT 1112747 E PT1112747 E PT 1112747E PT 00204630 T PT00204630 T PT 00204630T PT 00204630 T PT00204630 T PT 00204630T PT 1112747 E PT1112747 E PT 1112747E
Authority
PT
Portugal
Prior art keywords
flagelos
flageline
antibodies against
inducing antibodies
salmonella vaccine
Prior art date
Application number
PT00204630T
Other languages
English (en)
Portuguese (pt)
Inventor
Petrus Johannes Maria Nuijten
Maarten Hendrik Witvliet
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PT1112747E publication Critical patent/PT1112747E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT00204630T 1999-12-28 2000-12-19 Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos PT1112747E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204564 1999-12-28

Publications (1)

Publication Number Publication Date
PT1112747E true PT1112747E (pt) 2004-10-29

Family

ID=8241112

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00204630T PT1112747E (pt) 1999-12-28 2000-12-19 Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos

Country Status (15)

Country Link
US (2) US20010021386A1 (cg-RX-API-DMAC7.html)
EP (1) EP1112747B1 (cg-RX-API-DMAC7.html)
JP (1) JP5745731B2 (cg-RX-API-DMAC7.html)
AT (1) ATE269104T1 (cg-RX-API-DMAC7.html)
AU (1) AU783508B2 (cg-RX-API-DMAC7.html)
BR (1) BR0006291B1 (cg-RX-API-DMAC7.html)
CA (1) CA2329676A1 (cg-RX-API-DMAC7.html)
DE (1) DE60011560T2 (cg-RX-API-DMAC7.html)
DK (1) DK1112747T3 (cg-RX-API-DMAC7.html)
ES (1) ES2222152T3 (cg-RX-API-DMAC7.html)
HU (1) HU226192B1 (cg-RX-API-DMAC7.html)
MX (1) MXPA00012796A (cg-RX-API-DMAC7.html)
PL (1) PL206377B1 (cg-RX-API-DMAC7.html)
PT (1) PT1112747E (cg-RX-API-DMAC7.html)
TR (1) TR200401569T4 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4751570B2 (ja) * 2002-09-11 2011-08-17 東レ・ダウコーニング株式会社 オルガノポリシロキサン変性多糖類およびその製造方法
PL2066339T3 (pl) 2006-09-18 2015-02-27 Univ Arkansas Kompozycje i sposoby zwiększania odpowiedzi immunologicznych
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
CA2704457A1 (en) * 2007-10-30 2009-05-07 Walter Bottje Compositions and methods of enhancing immune responses to flagellated bacterium
AU2008318357B2 (en) 2007-11-01 2015-01-22 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to eimeria
WO2009062112A2 (en) 2007-11-09 2009-05-14 The Salk Institute For Biological Studies Use of tam receptor inhibitors as antimicrobials
DK2525817T3 (en) 2010-01-21 2017-10-02 Univ Arkansas Vaccine vectors and methods for enhancing immune responses
NZ718006A (en) 2010-06-09 2017-06-30 Univ Arkansas Vaccine and methods to reduce campylobacter infection
KR101449417B1 (ko) 2012-06-20 2014-10-27 한국외국어대학교 연구산학협력단 살모넬라 엔테리카의 박테리오파아지 및 그 용도
RU2683027C2 (ru) 2012-12-20 2019-03-26 Заклад Бадавчо-Вдроженёвы Осьродка Сальмонельля "Иммуноляб" Сп. З О.О. Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию
CA2900644C (en) 2013-02-14 2023-03-14 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
WO2014164607A1 (en) 2013-03-11 2014-10-09 The Brigham And Women's Hospital, Inc. Vibro-based delivery system and immune suppression
AU2014239557B2 (en) 2013-03-15 2019-01-03 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to enteric pathogens
TWI843057B (zh) 2016-05-03 2024-05-21 阿肯色州大學董事會 包含免疫刺激性及抗原性多肽的酵母菌疫苗載體以及其使用方法
CN111374094B (zh) * 2020-03-02 2022-04-19 扬州大学 驴源马流产沙门氏菌经皮下致非妊娠期小鼠子宫感染模型的建立方法
CN118773056B (zh) * 2024-07-10 2025-07-08 山东省滨州畜牧兽医研究院 一种马流产沙门氏菌灭活疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1109179A (en) * 1964-09-30 1968-04-10 Nat Res Dev Improvements relating to typhoid and paratyphoid vaccines
ES2060580T3 (es) * 1986-03-11 1994-12-01 Shionogi & Co Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.
DE68922394T2 (de) * 1988-05-05 1995-10-05 Praxis Biolog Inc Rekombinante vakzine von flagellin.
US6130082A (en) * 1988-05-05 2000-10-10 American Cyanamid Company Recombinant flagellin vaccines
JP3436756B2 (ja) * 1988-12-19 2003-08-18 アメリカン・サイアナミド・カンパニー 髄膜炎菌のクラスｉの外膜タンパク質のワクチン
DE69528450T2 (de) * 1994-02-18 2003-01-23 Solidose, L.L.C. Impfung von tieren mit getrockneten pelletierten biologischen materialien
GB9621091D0 (en) * 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US6190669B1 (en) * 1998-05-13 2001-02-20 University Of Maryland, Baltimore Attenuated mutants of salmonella which constitutively express the Vi antigen

Also Published As

Publication number Publication date
DK1112747T3 (da) 2004-10-25
MXPA00012796A (es) 2002-05-23
EP1112747B1 (en) 2004-06-16
DE60011560D1 (de) 2004-07-22
BR0006291B1 (pt) 2014-02-18
DE60011560T2 (de) 2005-08-18
PL206377B1 (pl) 2010-08-31
US20080069843A1 (en) 2008-03-20
AU783508B2 (en) 2005-11-03
ES2222152T3 (es) 2005-02-01
JP2001186874A (ja) 2001-07-10
BR0006291A (pt) 2001-11-27
HUP0005010A2 (en) 2002-06-29
EP1112747A1 (en) 2001-07-04
PL344851A1 (en) 2001-07-02
JP5745731B2 (ja) 2015-07-08
ATE269104T1 (de) 2004-07-15
TR200401569T4 (tr) 2004-07-21
HU226192B1 (en) 2008-06-30
US20010021386A1 (en) 2001-09-13
AU7245300A (en) 2001-07-05
HU0005010D0 (cg-RX-API-DMAC7.html) 2001-02-28
HUP0005010A3 (en) 2004-07-28
CA2329676A1 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
PT1112747E (pt) Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos
EP1499191A4 (en) REGULATED ATTENUATION OF LIVE VACCINES TO ENHANCE CROSS-PROTECTIVE IMMUNOGENICITY
HUP0203056A1 (hu) Vakcinakészítmény
ATE426412T1 (de) Adjuvante influenza-vakzine
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
ATE549032T1 (de) Adjuvanzverbindungen zur verbesserung von immunreaktionen auf polynukleotid-basierten impfstoffen
MY149604A (en) C.perfringens alpha toxoid vaccine
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
ATE346609T1 (de) Kombinierte meningitis b/c impfstoffe
CY1108178T1 (el) Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου
DK1395283T3 (da) Heterolog beskyttelse induceret ved immunisering med Invaplex-vaccine
DE60124526D1 (de) Methode zur identifizierung von helicobacter antigenen
EA200702254A1 (ru) Вакцинная композиция, содержащая в-субъединицу термолабильного токсина e.coli и антиген и адъювант
DE60115051D1 (de) Immunologische adjuvans verbindungen
MXPA02012857A (es) Uso de una formulacion elaborada de o que contiene al menos un suero de leche dismilado.
ES2502366T3 (es) Inducción de inmunidad tumoral por variantes de proteína de unión a folato
ATE270112T1 (de) Streptococcus equi impfstoff
DE60042489D1 (de) Impfstoff gegen neisseria infektion
SG147465A1 (en) Vaccine
ATE359815T1 (de) Streptococcus-phocae-vakzine
DK1074266T3 (da) Levende svækkede bakterier til anvendelse i vaccine
WO2005021031A3 (en) Live attenuated bacterial vaccine
RU99117151A (ru) Штамм бактерий pseudomonas aeruginosa 5002, используемый для изготовления вакцины против псевдомоноза пушных зверей
CY1114309T1 (el) Εμβολιο ροταϊου
RU99117153A (ru) Штамм бактерий pseudomonas aeruginosa 4762, используемый для изготовления вакцины против псевдомоноза пушных зверей